Drug metabolising N-acetyltransferase activity in human cell lines
- 9 April 1991
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1073 (3) , 593-599
- https://doi.org/10.1016/0304-4165(91)90235-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Determination of molecular weights and frictional ratios of proteins in impure systems by use of gel filtration and density gradient centrifugation. Application to crude preparations of sulfite and hydroxylamine reductasesPublished by Elsevier ,2003
- Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.Journal of Clinical Investigation, 1990
- Arylamine N-acetyltransferase from fast (C57BL6) and slow (A/J) N-Acetylating strains of miceBiochemical Pharmacology, 1990
- Evidence for two closely related isozymes of arylamine N‐acetyltransferase in human liverFEBS Letters, 1989
- Human adult hepatocytes in primary monolayer cultureBiochemical Pharmacology, 1987
- Induction of drug metabolizing enzymes in human liver cell line Hep G2FEBS Letters, 1985
- ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCERThe Lancet, 1982
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Partial purification and properties of the isoniazid transacetylase in human liver. Its relationship to the acetylation of p-aminosalicylic acid.Journal of Clinical Investigation, 1965
- Genetic Control of Isoniazid Metabolism in ManBMJ, 1960